371 related articles for article (PubMed ID: 24373993)
1. 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.
Gavin AM; Walsh S; Wyatt S; O'Keeffe GW; Sullivan AM
Neurosci Lett; 2014 Feb; 561():176-81. PubMed ID: 24373993
[TBL] [Abstract][Full Text] [Related]
2. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
Jaumotte JD; Zigmond MJ
J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
[TBL] [Abstract][Full Text] [Related]
3. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat.
Mertens B; Massie A; Michotte Y; Sarre S
Neuroscience; 2009 Aug; 162(1):148-54. PubMed ID: 19383530
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
[TBL] [Abstract][Full Text] [Related]
6. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
Lei Z; Jiang Y; Li T; Zhu J; Zeng S
J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
8. Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.
Kramer ER; Aron L; Ramakers GM; Seitz S; Zhuang X; Beyer K; Smidt MP; Klein R
PLoS Biol; 2007 Mar; 5(3):e39. PubMed ID: 17298183
[TBL] [Abstract][Full Text] [Related]
9. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.
Smith AD; Antion M; Zigmond MJ; Austin MC
Brain Res Mol Brain Res; 2003 Oct; 117(2):129-38. PubMed ID: 14559146
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
11. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
12. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
14. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
Lu X; Hagg T
J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
18. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
[TBL] [Abstract][Full Text] [Related]
19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]